Protocol to request
Randomization of in vivo efficacy experiments
Research article
NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats
JP Johnson et al.
DOI: 10.7554/eLife.72468